New Therapy Might Help When Melanoma Spreads to Brain

Medical Marvels: Using immunotherapy for melanoma that spread to the brain

Show Description

NewYork-Presbyterian is one of the nation’s most comprehensive academic health care delivery systems, dedicated to providing the highest quality, most compassionate care to patients in the New York metropolitan area and throughout the globe. In collaboration with two renowned medical schools, Weill Cornell Medicine and Columbia University College of Physicians & Surgeons, NewYork-Presbyterian is consistently recognized as a leader in medical education, ground-breaking research and innovative, patient-centered clinical care.

Video taken from the channel: NewYork-Presbyterian Hospital

Managing Brain Metastases in Melanoma

Show Description

Jeffrey S. Weber, MD, PhD; Axel Hauschild, MD, PhD; Caroline Robert, MD, PhD; and Reinhard G. Dummer, MD, consider the systemic and stereotactic radiotherapy approaches to treating melanoma brain metastases.

Video taken from the channel: OncLiveTV

Treatment of Brain Metastasis

Show Description

Presentation given by Erik Sulman, MD, PhD, as part of the AIM at Melanoma’s Patient & Caregiver Symposium on August 15, 2015 at MD Anderson Cancer Center in Houston, TX.

Video taken from the channel: AIMatMelanoma

Metastatic Melanoma Brain Metastases

Show Description

Experts discuss the use of nivolumab-ipilimumab for the treatment of melanoma brain metastases.

Video taken from the channel: OncLiveTV

Treatment of Brain Metastases | Won Kim, MD | UCLAMDChat

Show Description

UCLA neurosurgeon Won Kim, MD, gives an overview of assessing and treating brain metastases, and an update on advancements in the field. Learn more: http://neurosurgery.ucla.edu/.
Learn more about Dr. Won Kim at https://www.uclahealth.org/won-kim

Video taken from the channel: UCLA Health

Treatment Options for Brain Metastasis

Show Description

Patient and Caregiver Symposium held in Houston, TX at MD Anderson Cancer Center in which Kevin Kim, MD and other melanoma experts discussed melanoma treatments and clinical trials.

Video taken from the channel: AIMatMelanoma

Melanoma brain metastases

Show Description

In this episode of Cancer Newsline, we discuss melanoma when it metastasizes to the brain and the types of therapies used to treat melanoma brain metastases..
Learn more about melanoma: https://www.mdanderson.org/cancer-types/melanoma.html.
Request an appointment at MD Anderson by calling 1-877-632-6789 or online at: https://my.mdanderson.org/RequestAppointment?cmpid=youtube_appointment_melanoma

Video taken from the channel: MD Anderson Cancer Center

THURSDAY, July 12, 2018 (HealthDay News) A type of therapy that harnesses the immune system is giving new hope to people battling a once hopeless cancer melanoma that’s spread to the brain. New research involving more than 2,700 U.S. patients is confirming what specialists in the field have long known that “checkpoint blockade” treatment can beat back these devastating. A type of therapy that harnesses the immune system is giving new hope to people battling a once hopeless cancer—melanoma that’s spread to the brain. THURSDAY, July 12, 2018 (HealthDay News) A type of therapy that harnesses the immune system is giving new hope to people battling a once hopeless cancer melanoma that’s spread to the brain. THURSDAY, July 12, 2018 A type of therapy that harnesses the immune system is giving new hope to people battling a once hopeless cancer melanoma that’s spread to the brain.

New research involving more than 2,700 U.S. patients is confirming what specialists in the field have long known that “checkpoint blockade” treatment can beat back these devastating tumors. THURSDAY, July 12, 2018 (HealthDay News) — A type of therapy that harnesses the immune system is giving new hope to people battling a once hopeless cancer — melanoma that’s spread to the brain. New research involving more than 2,700 U.S. patients is confirming what specialists in the field have long known — that “checkpoint blockade” treatment can beat back these devastating.

Immune Therapy May Help Melanoma in the Brain. THURSDAY, July 12, 2018 (HealthDay News) A type of therapy that harnesses the immune system is giving new hope to people battling a once hopeless. THURSDAY, July 12, 2018 (HealthDay News) — A type of therapy that harnesses the immune system is giving new hope to people battling a once hopeless cancer — melanoma that’s spread to the brain. New research involving more than 2,700 U.S. patients is confirming what specialists in the field have long known — that “checkpoint blockade” treatment can beat back these devastating.

Immune-Based Therapy May Help When Melanoma Spreads to Brain THURSDAY, July 12, 2018 (HealthDay News) — A type of therapy that harnesses the immune system is giving new hope to people battling a once hopeless cancer — melanoma that’s spread to the brain. Research shows that the earlier melanoma is found in the brain, the more effective treatment can be. When melanoma spreads to the brain, the treatment plan may include: Surgery: Doctors may recommend surgery to: Remove the tumor. Reduce the size of a tumor. This can make other treatments more effective.

Immune-Based Therapy May Help When Melanoma Spreads to Brain By Weekly Sauce | July 12, 2018 A type of therapy that harnesses the immune system is giving new hope to people battling a once hopeless cancer — melanoma that’s spread to the brain. Using immunotherapy to treat melanoma that has spread to the brain can significantly improve survival, according to a new analysis of nationwide cancer data in.

List of related literature:

Brain metastases, which are quite often present (55-75%) in melanoma patients, also require a treatment to relieve symptoms, and available options depend on the number and location of lesions.
from Textbook of Medical Oncology by Stan B. Kaye`, Stan B Kaye Taylor & Francis, 2004
Therefore, developing new target for therapy is of particular significance in combating metastatic melanoma.
from AACR 2018 Proceedings: Abstracts 1-3027 by American Association for Cancer Research CTI Meeting Technology, 2018
The intersection of immune-directed and molecularly targeted therapy in advanced melanoma; where we have been, are, and will be.
from Weedon’s Skin Pathology E-Book by James W Patterson Elsevier Health Sciences, 2019
Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
from Schmidek and Sweet: Operative Neurosurgical Techniques E-Book: Indications, Methods and Results (Expert Consult Online and Print) by Alfredo Quinones-Hinojosa Elsevier Health Sciences, 2012
BRAF targeted therapy changes the treatment paradigm in melanoma.
from Holland-Frei Cancer Medicine Cloth by Robert C. Bast, Jr., Carlo M. Croce, et. al. Wiley, 2017
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.
from Dermatology E-Book by Jean L. Bolognia, Joseph L. Jorizzo, Julie V. Schaffer Elsevier Health Sciences, 2012
Molecular targeted therapy approaches for BRAF wild-type melanoma.
from Genomic Applications in Pathology by George Jabboure Netto, Karen L. Kaul Springer International Publishing, 2018
Finally, the addition of ricolinostat treatment to either anti­CTLA4 or anti­PD1 treatment was associated with an enhanced inhibition of melanoma tumor growth.
from AACR 2017 Proceedings: Abstracts 3063-5947 by American Association for Cancer Research CTI Meeting Technology, 2017
The efficacy of various agents in treating patients with brain metastases from primary melanoma have been studied, largely without success.
from Abeloff’s Clinical Oncology E-Book by Martin D. Abeloff, James O. Armitage, et. al. Elsevier Health Sciences, 2008
Introduction: While immunotherapy is a promising treatment option for advanced metastatic disease, the survival benefit of adding ipilimumab to stereotactic radiosurgery (SRS) in unselected patients with metastases to the brain seems limited [1, 2].
from AACR 2016: Abstracts 1-2696 by American Association for Cancer Research (AACR) CTI Meeting Technology, 2016